Close
ACHEMA MIDDLE EAST 2026

FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters

The Vaccines and Related Biological Products Advisory Panel of the U.S. Food and Drug Administration gathered on June 30th to evaluate whether a change to...

FDA Experts Recommend Changing COVID Jab Formulation In Fall

To address more recently circulating coronavirus strains, advisors to the U.S. Food and Drug Administration recently suggested altering the design of COVID-19 booster doses this...

Australia Creates A Novel Stem Cell Production Technique

A novel 3D printed methodology for extracting stem cells from bioreactors has been created by researchers at the University of Technology, Sydney, opening the...

U.S. Officials Clear COVID-19 Jab For Infants, Preschoolers

The first COVID-19 vaccines for newborns and preschoolers were approved by US regulators on Friday, June 17, paving the path for inoculation to begin...

FDA Officials Support Moderna, Pfizer COVID-19 Jabs For Kids

Parents may soon be allowed to line up their children for vaccinations after Pfizer and Moderna's COVID-19 vaccine application for young children progresses through...

FDA Not So Fast On Approval Of The Novavax COVID-19 Vaccine

The US handed Novavax a $1.6 billion funding 4 months into the pandemic, in July 2020, to speed the biotech's research of a coronavirus...

FDA Rebukes Althera On Cholesterol Medication Assertions

Althera Pharmaceuticals, a producer of cardiovascular drugs, is being investigated by the FDA for its cholesterol oral delivery medicine, Roszet. The FDA's Office of...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...